
|Videos|January 30, 2012
Preventing Pneumococcal Disease
Advertisement
Populations at risk for developing pneumococcal disease, including seniors, can benefit from the preventive protection of vaccination. Many adults who are older than 65 years did not receive any vaccination against pneumococcal disease as a child. In addition, adults with comorbid conditions are at additional risk for developing pneumococcal infection, and should educate themselves on the benefits of vaccination for preventing potentially life-threatening illness.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
US Measles Cases Climb, Raising Questions About Preparedness and Prevention
2
FDA Awards National Priority Voucher to Teclistamab Plus Daratumumab in Relapsed/Refractory Multiple Myeloma
3
Afamitresgene autoleucel: The First T-Cell Receptor Therapy on the Market
4
Soaring off the Patent Cliff: Preparing for the Next Wave of Oncology Biosimilars
5










































































































































































































